Wim Souverijns - 15 May 2026 Form 4 Insider Report for Pharvaris N.V. (PHVS)

Reporting relationship: Chief Commercial Officer
Issuer ticker: PHVS
Reported as of: 15 May 2026
Net transaction value: -$299,163
SEC form: 4
Accepted by SEC: 19 May 2026, 18:42:49 UTC
Prior SEC filing: 18 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Marnus Nel, Attorney-in-Fact for Wim Souverijins

Key filing fact

Wim Souverijns filed Form 4 for Pharvaris N.V. (PHVS) on 19 May 2026.

Key facts

This page summarizes Wim Souverijns's Form 4 filing for Pharvaris N.V. (PHVS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 19 May 2026, 18:42.

Change

Previous filing in this sequence was filed on 18 Mar 2026.
Current net transaction value: -$299,163.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001973529 Primary reporting owner

Souverijns Wim

Relationship: Chief Commercial Officer
Address: 1 CRANBERRY HILL SUITE 400, LEXINGTON
Signature: /s/ Marnus Nel, Attorney-in-Fact for Wim Souverijins
Signature date: 19 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PHVS transaction

Common Stock

Sale

Transaction value: $299,163
Shares: -10,000
Change %: -18%
Price: $29.92
Shares after: 45,111
Date: 15 May 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

This is a scheduled sale from 10b5-1 trading plan.

Footnote F2

The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares reported herein include shares of common stock acquired upon vesting of restricted stock units on various dates. The sales prices for the transactions ranged from $29.725 to $30.08. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.